Log In
BCIQ
Print this Print this
 

TGSC01AA(4)

  Manage Alerts
Collapse Summary General Information
Company Fabre-Kramer Pharmaceuticals Inc.
DescriptionFlavonoid compounds
Molecular Target Benzodiazepine receptor
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationAnxiety
Indication DetailsTreat anxiety
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today